Bio-Rad Laboratories Total Non-Cash Items 2010-2024 | BIO
Bio-Rad Laboratories annual/quarterly total non-cash items history and growth rate from 2010 to 2024. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
- Bio-Rad Laboratories total non-cash items for the quarter ending December 31, 2024 were $0.106B, a 1.94% decline year-over-year.
- Bio-Rad Laboratories total non-cash items for the twelve months ending December 31, 2024 were $0.249B, a 10.29% decline year-over-year.
- Bio-Rad Laboratories annual total non-cash items for 2024 were $0.106B, a 1.94% decline from 2023.
- Bio-Rad Laboratories annual total non-cash items for 2023 were $0.108B, a 26.37% increase from 2022.
- Bio-Rad Laboratories annual total non-cash items for 2022 were $0.086B, a 79.11% increase from 2021.
| Bio-Rad Laboratories Annual Total Non-Cash Items (Millions of US $) |
|
|---|---|
| 2024 | $106 |
| 2023 | $108 |
| 2022 | $86 |
| 2021 | $48 |
| 2020 | $18 |
| 2019 | $32 |
| 2018 | $34 |
| 2017 | $1 |
| 2016 | $-3 |
| 2015 | $13 |
| 2014 | $-33 |
| 2013 | $16 |
| 2012 | $7 |
| 2011 | $9 |
| 2010 | $-3 |
| 2009 | $9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $6.620B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||